Sponsor study identifier
interventional
19
1 country
1
Study Start
June 2016
Actual (reported)Primary Completion
May 2018
Actual (reported)Study Completion
May 2018
Actual (reported)This study will test feasibility, in smokers with lung, head \& neck, and bladder cancers, that examines the effect of e-cigarette substitution, on measures of smoking-related toxicity and medical outcomes. The aim of the study is to determine the appeal of e-cigarettes compared to regular combustible cigarettes.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 5, 2016
Actual (reported)January 6, 2016
Actual (reported)June 2016
Actual (reported)May 2018
Actual (reported)May 2018
Actual (reported)September 19, 2019
Actual (reported)Change in Daily Cigarette Smoking Given 10 or More E-cigarette Sessions in a Day
Participants report of daily cigarette and e-cigarette use for the previous 7 days at each study time-point (baseline and 3, 6, 9, and 12 weeks post-baseline) will be averaged to create usual daily cigarette. Mixed-effects linear regression with a random effect at the participant level will be used to assess the association between usual cigarette use (dependent variable) and usually e-cigarette use (independent predictor) over the study period while accounting for the repeated measures within subject. The model will be fit using restricted maximum likelihood. Time will be included in the model as continuous and categorical, separately, and we assess for stability of the association between cigarette use and e-cigarette over time by including an interaction term between e-cigarette use and time in the model.
12 Weeks
Average Number of E-cigarettes Used Per Day
Average number of e-cigarettes used per day over the 12 week period
12 Weeks
HALO cigalike model
HALO tank model
HALO manufactures e-cigarettes which will be distributed to patients. Two products, the G6 and tank model will be used.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
James D Sargent, MD
Dartmouth College
19 participants (actual enrollment reported by the registry).
First Submitted
January 5, 2016
First Posted
January 6, 2016
Study Start
June 2016
Actual (reported)A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer Surgery
Contact the study team to confirm eligibility.
Primary Completion
May 2018
Actual (reported)Study Completion
May 2018
Actual (reported)Last Updated
September 19, 2019
Results First Posted
September 19, 2019
Record last verified: 2019-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: